NEW: Premarket Now Starts at 4AM!

We’re excited to announce the extension of premarket and aftermarket hours! Our members now have access to quotes daily from 4:00 AM to 8:00 PM ET — offering greater flexibility and deeper insights into market trends beyond regular trading hours.

Upgrade to FINVIZ*Elite to access premarket quotes »

GMED

Globus Medical Inc

May 22 • 04:00PM ET

58.60

Dollar change -0.68
Percentage change -1.15	%

Healthcare • Medical Devices • USA • NYSE

Peers: JNJ SYK BSX ZBH BAX MEDP HOLX IART MTD TFX

| Held by: VTI IJH VB VXF VBK MDY IJK XMMO IHI SCHA

Scroll to Statements

Index	-	P/E	43.83	EPS (ttm)	1.34	Insider Own	17.15%	Shs Outstand	112.93M	Perf Week	1.35%
Market Cap	7.93B	Forward P/E	15.73	EPS next Y	3.73	Insider Trans	-0.89%	Shs Float	112.16M	Perf Month	-18.37%
Income	185.56M	PEG	4.41	EPS next Q	0.79	Inst Own	82.41%	Short Float	3.76%	Perf Quarter	-27.01%
Sales	2.51B	P/S	3.16	EPS this Y	1.75%	Inst Trans	3.31%	Short Ratio	2.72	Perf Half Y	-28.39%
Book/sh	30.20	P/B	1.94	EPS next Y	16.61%	ROA	3.84%	Short Interest	4.22M	Perf Year	-11.56%
Cash/sh	3.41	P/C	17.20	EPS next 5Y	9.94%	ROE	4.63%	52W Range	54.48 - 94.93	Perf YTD	-29.15%
Dividend Est.	-	P/FCF	15.18	EPS past 5Y	-13.26%	ROI	4.45%	52W High	-38.27%	Beta	1.23
Dividend TTM	-	Quick Ratio	2.72	Sales past 5Y	28.52%	Gross Margin	55.88%	52W Low	7.56%	ATR (14)	2.63
Dividend Ex-Date	-	Current Ratio	4.45	EPS Y/Y TTM	112.87%	Oper. Margin	11.99%	RSI (14)	34.77	Volatility	2.01% 6.29%
Employees	5300	Debt/Eq	0.02	Sales Y/Y TTM	32.26%	Profit Margin	7.39%	Recom	1.81	Target Price	85.17
Option/Short	Yes / Yes	LT Debt/Eq	0.02	EPS Q/Q	1126.43%	Payout	0.00%	Rel Volume	1.07	Prev Close	59.28
Sales Surprise	-4.44%	EPS Surprise	-8.60%	Sales Q/Q	-1.41%	Earnings	May 08 AMC	Avg Volume	1.55M	Price	58.60
SMA20	-10.42%	SMA50	-15.78%	SMA200	-23.31%	Trades		Volume	1,660,626	Change	-1.15%

Date	Action	Analyst	Rating Change	Price Target Change
Jan-10-25	Upgrade	BofA Securities	Underperform → Neutral	$97
Dec-02-24	Upgrade	Morgan Stanley	Equal-Weight → Overweight	$83 → $100
Aug-07-24	Upgrade	Wells Fargo	Equal Weight → Overweight	$60 → $78
May-20-24	Upgrade	Piper Sandler	Neutral → Overweight	$60 → $80
Mar-18-24	Upgrade	BTIG Research	Neutral → Buy	$60
Oct-20-23	Initiated	ROTH MKM	Buy	$75
Sep-19-23	Upgrade	Stifel	Hold → Buy	$61
Mar-30-23	Upgrade	Canaccord Genuity	Hold → Buy	$67
Feb-13-23	Downgrade	BofA Securities	Buy → Underperform	$83 → $63
Feb-10-23	Downgrade	Wells Fargo	Overweight → Equal Weight	$67
Feb-10-23	Downgrade	Truist	Buy → Hold	$85 → $70
Feb-10-23	Downgrade	Needham	Buy → Hold
Feb-10-23	Downgrade	Loop Capital	Buy → Hold	$90 → $70
Feb-10-23	Downgrade	BTIG Research	Buy → Neutral
Oct-18-22	Initiated	Barclays	Overweight	$69
Oct-12-22	Initiated	Jefferies	Buy	$75
Apr-13-22	Resumed	Truist	Buy	$80 → $91
Mar-28-22	Initiated	Wells Fargo	Overweight	$80
Jan-04-22	Upgrade	Piper Sandler	Neutral → Overweight	$80 → $88
Dec-13-21	Upgrade	BofA Securities	Underperform → Buy	$55 → $80

Show Previous Ratings

May-15-25 04:30PM	Globus Medical Announces $500 Million Share Repurchase Program (GlobeNewswire) +5.93%
May-12-25 07:24AM	GMED Q1 Earnings & Revenues Miss, '25 EPS View Down, Stock Falls (Zacks) +5.71%
May-09-25 08:22AM	Q1 2025 Globus Medical Inc Earnings Call (Thomson Reuters StreetEvents) -22.96%
03:39AM	Globus Medical Inc (GMED) Q1 2025 Earnings Call Highlights: Navigating Challenges with ... (GuruFocus.com)
May-08-25 06:30PM	Globus Medical (GMED) Reports Q1 Earnings: What Key Metrics Have to Say (Zacks)
05:45PM	Loading…
05:45PM	Globus Medical (GMED) Lags Q1 Earnings and Revenue Estimates (Zacks)
04:43PM	Globus Medical: Q1 Earnings Snapshot (Associated Press Finance)
04:15PM	Globus Medical Reports First Quarter 2025 Results (GlobeNewswire)
May-07-25 07:55PM	RxSight, Inc. (RXST) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
12:42PM	Globus Medical Q1 2025 Earnings Preview (Seeking Alpha)
May-06-25 08:20AM	Neuronetics (STIM) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
06:20AM	Should Invesco S&P MidCap 400 Pure Growth ETF (RFG) Be on Your Investing Radar? (Zacks)
May-05-25 09:15AM	Gear Up for Globus Medical (GMED) Q1 Earnings: Wall Street Estimates for Key Metrics (Zacks)
May-01-25 06:05PM	Alphatec (ATEC) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
10:01AM	Globus Medical (GMED) Earnings Expected to Grow: Should You Buy? (Zacks)
07:27AM	Loading…
07:27AM	4 MedTech Stocks Poised to Outshine Q1 Earnings Estimates (Zacks)
Apr-30-25 09:01AM	Strong Segmental Performance to Drive Stryker's Q1 Earnings? (Zacks)
Apr-29-25 09:05AM	DXCM Q1 Earnings to Reflect U.S. Coverage Expansion & Stelo Impact? (Zacks)
Apr-28-25 01:19PM	Will BAX's Q1 Earnings Improve Following Transformation Completion? (Zacks)
Apr-25-25 08:00AM	Segmental Performance to Drive RVTY's Q1 Earnings: Is a Beat Likely? (Zacks)
05:07AM	Globus Medical (GMED): Buy, Sell, or Hold Post Q4 Earnings? (StockStory)
Apr-23-25 07:12PM	Globus Medical: Digesting Another Acquisition (Seeking Alpha)
Apr-22-25 09:45AM	Why Globus Medical (GMED) is a Top Growth Stock for the Long-Term (Zacks)
09:11AM	Is the Options Market Predicting a Spike in Globus Medical (GMED) Stock? (Zacks)
08:12AM	Will Segmental Performance Drive West Pharmaceutical's Q1 Earnings? (Zacks)
Apr-18-25 12:10PM	Will Globus Medical (GMED) Beat Estimates Again in Its Next Earnings Report? (Zacks)
Apr-17-25 04:30PM	Globus Medical Schedules First Quarter Earnings Release and Conference Call (GlobeNewswire)
Apr-14-25 12:18PM	International Growth Drives GMED Stock Amid Fierce Competition (Zacks)
Apr-07-25 08:37AM	GMED Stock May Benefit Following the Acquisition of Nevro (Zacks)
Apr-04-25 05:42AM	Globus acquires US medical device company Nevro (Medical Device Network)
08:31AM	Loading…
Apr-03-25 08:31AM	Globus Medical completes acquisition of Nevro Corp. (GlobeNewswire)
Mar-21-25 08:22AM	GMED Stock Jumps 41.8% in a Year: What's Behind the Rally? (Zacks)
Mar-19-25 10:02AM	Should You Hold Globus Medical Stock in Your Portfolio Now? (Zacks)
Mar-11-25 04:40PM	Globus Medical extends versatility of Advanced Materials Science anterior interbody portfolio with launch of COHERE ALIF Spacer and Modulus ALIF Blades (GlobeNewswire)
05:04AM	Medical Devices & Supplies - Specialty Stocks Q4 In Review: Globus Medical (NYSE:GMED) Vs Peers (StockStory)
Mar-06-25 04:40PM	Globus Medical to feature ExcelsiusFlex for Total Knee Arthroplasty at the American Academy of Orthopedic Surgeons Annual Meeting (GlobeNewswire)
Mar-05-25 07:01PM	Globus Medical to participate in the Canaccord Genuity 2025 Musculoskeletal Conference (GlobeNewswire)
09:13AM	Is the Options Market Predicting a Spike in Globus Medical (GMED) Stock? (Zacks)
Mar-04-25 11:47PM	Is Globus Medical, Inc. (GMED) the Best Medical Technology Stock to Buy According to Analysts? (Insider Monkey)
04:15PM	Nevro Reports Fourth-Quarter and Full-Year 2024 Financial Results (PR Newswire)
08:06AM	1 Mid-Cap Stock to Target This Week and 2 to Avoid (StockStory)
Feb-21-25 02:15AM	Globus Medical Inc (GMED) Q4 2024 Earnings Call Highlights: Record Revenue and Strategic ... (GuruFocus.com)
Feb-20-25 10:00PM	Globus Medical (GMED) Q4 2024 Earnings Call Transcript (Motley Fool)
07:00PM	Globus Medical (GMED) Reports Q4 Earnings: What Key Metrics Have to Say (Zacks)
05:55PM	Globus Medical (GMED) Q4 Earnings and Revenues Top Estimates (Zacks)
05:04PM	Globus Medical: Q4 Earnings Snapshot (Associated Press Finance)
04:58PM	Globus Medicals (NYSE:GMED) Q4 Sales Beat Estimates (StockStory)
04:15PM	Globus Medical Reports Fourth Quarter and Full Year 2024 Results (GlobeNewswire)
Feb-19-25 08:08AM	Globus Medical (GMED) Q4 Earnings: What To Expect (StockStory)
Feb-17-25 09:16AM	Globus Medical (GMED) Q4 Earnings on the Horizon: Analysts' Insights on Key Performance Measures (Zacks)
Feb-13-25 10:01AM	Globus Medical (GMED) Reports Next Week: Wall Street Expects Earnings Growth (Zacks)
Feb-10-25 12:55PM	Globus Medical strengthens SCS market position with $250m Nevro deal (Medical Device Network)
Feb-07-25 09:35AM	Globus Medical to acquire Nevro for $5.85 per share (TipRanks)
Feb-06-25 01:49PM	Globus Medical to Acquire Nevro in $250 Million Deal to Expand Chronic Pain Treatment Portfolio (GuruFocus.com)
11:40AM	Globus to buy Nevro for $250M (MedTech Dive)
09:30AM	Globus Medical to Acquire Nevro Corp. to Expand Treatment Options for Patients (GlobeNewswire)
08:30AM	Dentsply Sirona Appoints Michael Barber and Daniel Scavilla as New Board Members (GlobeNewswire)
Feb-05-25 09:45AM	Globus Medical (GMED) is a Top-Ranked Growth Stock: Should You Buy? (Zacks)
Jan-30-25 04:35PM	Globus Medical Schedules Fourth Quarter and Full Year 2024 Earnings Release and Conference Call (GlobeNewswire)
Jan-23-25 09:50AM	Why Globus Medical (GMED) is a Top Momentum Stock for the Long-Term (Zacks)
Jan-20-25 12:10PM	Will Globus Medical (GMED) Beat Estimates Again in Its Next Earnings Report? (Zacks)
09:45AM	Here's Why Globus Medical (GMED) is a Strong Growth Stock (Zacks)
Jan-10-25 03:24PM	Outlook For These Biotechs Brightens As FDA Ushers In New Rules For Sector (Investor's Business Daily)
01:28PM	These Oil And Gas Names Hit Highs As Energy Prices Jump (Investor's Business Daily)
08:20AM	Globus Medical upgraded to Neutral from Underperform at BofA (TipRanks)
Jan-08-25 04:30PM	Globus Medical Reports Preliminary Record Fourth Quarter and Full Year Sales Results (GlobeNewswire)
Jan-06-25 12:19PM	Globus Medical Stock Revs Up For Next Move After 70% Run (Investor's Business Daily)
Jan-02-25 09:45AM	Why Globus Medical (GMED) is a Top Growth Stock for the Long-Term (Zacks)
Dec-19-24 07:30AM	Globus Medical price target raised to $90 from $85 at Truist (TipRanks)
Dec-11-24 02:59PM	Inari Medical Stock Gets RS Rating Upgrade (Investor's Business Daily)
Dec-05-24 12:00PM	What Makes Globus Medical (GMED) a New Buy Stock (Zacks)
11:30AM	Globus Medical (GMED) Up 2.1% Since Last Earnings Report: Can It Continue? (Zacks)
Dec-03-24 02:51PM	Novocure Stock Earns 96 RS Rating (Investor's Business Daily)
Dec-02-24 02:21PM	Here's Why Globus Medical (GMED) is a Strong Value Stock (Zacks)
01:49PM	Why Is Globus Medical, Inc. (GMED) Among the Best High Growth Healthcare Stocks to Invest In Now? (Insider Monkey)
Nov-29-24 12:45PM	3 Reasons Why Growth Investors Shouldn't Overlook Globus Medical (GMED) (Zacks)
Nov-22-24 04:30PM	Globus Medical Launches ExcelsiusHub Navigation System (GlobeNewswire)
09:15AM	Globus Medical, Inc. (GMED) Hit a 52 Week High, Can the Run Continue? (Zacks)
Nov-15-24 09:50AM	Globus Medical (GMED) is a Top-Ranked Momentum Stock: Should You Buy? (Zacks)
Nov-14-24 09:40AM	Why Globus Medical (GMED) is a Top Value Stock for the Long-Term (Zacks)
Nov-13-24 12:45PM	Is Globus Medical (GMED) a Solid Growth Stock? 3 Reasons to Think "Yes" (Zacks)
Nov-12-24 06:50AM	Globus Medical price target raised to $83 from $74 at Morgan Stanley (TipRanks)
Nov-11-24 09:45AM	Globus Medical (GMED) is a Top-Ranked Growth Stock: Should You Buy? (Zacks)
Nov-06-24 07:36AM	Q3 2024 Globus Medical Inc Earnings Call (Thomson Reuters StreetEvents) +9.43%
02:21AM	Globus Medical Inc (GMED) Q3 2024 Earnings Call Highlights: Record Revenue and Strategic Growth ... (GuruFocus.com)
12:07AM	Decoding Globus Medical Inc (GMED): A Strategic SWOT Insight (GuruFocus.com)
Nov-05-24 09:15PM	Globus Medical (GMED) Q3 2024 Earnings Call Transcript (Motley Fool)
06:00PM	Globus Medical (GMED) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
05:25PM	Globus Medical (GMED) Beats Q3 Earnings and Revenue Estimates (Zacks)
04:33PM	Globus Medical: Q3 Earnings Snapshot (Associated Press Finance)
04:15PM	Globus Medical Reports Third Quarter 2024 Results (GlobeNewswire)
Nov-03-24 01:38PM	Is a Globus Medical, Inc. (GMED) Promising Medical Stock with Growth Potential? (Insider Monkey)
Oct-31-24 09:15AM	Gear Up for Globus Medical (GMED) Q3 Earnings: Wall Street Estimates for Key Metrics (Zacks)
Oct-18-24 04:30PM	Globus Medical to Participate in Orthopedic Trauma Association Annual Meeting (GlobeNewswire)
Oct-15-24 04:30PM	Globus Medical Schedules Third Quarter Earnings Release and Conference Call (GlobeNewswire)
07:37AM	Globus Medical price target raised to $78 from $77 at BTIG (TipRanks)
Oct-02-24 04:15PM	Globus Medical Launches the Next Wave of Orthopedic Trauma Solutions (GlobeNewswire)
Sep-09-24 09:00PM	Bragar Eagel & Squire, P.C. Is Investigating MaxLinear, Customers Bancorp, Globus, and Domino's and Encourages Investors to Contact the Firm (GlobeNewswire)
Sep-05-24 11:31AM	Why Is Globus Medical (GMED) Down 0.2% Since Last Earnings Report? (Zacks)
Aug-30-24 09:00PM	Bragar Eagel & Squire, P.C. Is Investigating Centuri, Medpace, Customers Bancorp, and Globus and Encourages Investors to Contact the Firm (GlobeNewswire)

Globus Medical, Inc. operates as a medical device company that develops and commercializes healthcare solutions. The firm engages in developing products that promote healing in patients with musculoskeletal disorders. It classifies products into Innovative Fusion and Disruptive Technology. It operates through the United States and International geographical segments. The company was founded by David C. Paul, David D. Davidar and Andrew Iott in March 2003 and is headquartered in Audubon, PA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
RHOADS ANN D	Director	Feb 28 '25	Sale	78.68	7,500	590,100	35,384	Mar 04 04:38 PM
RHOADS ANN D	Director	Feb 28 '25	Proposed Sale	78.67	7,500	590,000		Feb 28 11:05 AM
Pfeil Keith W	COO, CFO	Jan 10 '25	Option Exercise	51.78	14,167	733,561	14,167	Jan 14 04:12 PM
Pfeil Keith W	COO, CFO	Jan 10 '25	Sale	88.29	14,167	1,250,770	0	Jan 14 04:12 PM
Pfeil Keith W	Officer	Jan 10 '25	Proposed Sale	88.29	14,167	1,250,772		Jan 10 11:20 AM
Huller Kelly	SVP, GC, Corporate Secretary	Dec 02 '24	Option Exercise	24.21	2,500	60,525	2,500	Dec 04 04:12 PM
Huller Kelly	SVP, GC, Corporate Secretary	Dec 02 '24	Sale	87.00	2,500	217,502	0	Dec 04 04:12 PM
Huller Kelly	Officer	Dec 02 '24	Proposed Sale	86.95	2,500	217,364		Dec 02 04:35 PM
Davidar David D	Director	Nov 21 '24	Sale	85.00	13,254	1,126,590	172,713	Nov 25 04:35 PM
Davidar David D	Director	Nov 21 '24	Sale	85.00	13,234	1,124,890	523,041	Nov 25 04:35 PM
Davidar David D	Director	Nov 22 '24	Sale	85.00	6,766	575,135	516,275	Nov 25 04:35 PM
Davidar David D	Director	Nov 22 '24	Sale	85.00	6,746	573,435	165,967	Nov 25 04:35 PM
Lemaitre Dan	Director	Nov 21 '24	Option Exercise	65.05	13,278	863,734	13,278	Nov 25 04:31 PM
Lemaitre Dan	Director	Nov 22 '24	Option Exercise	65.05	1,097	71,360	1,097	Nov 25 04:31 PM
Lemaitre Dan	Director	Nov 21 '24	Sale	85.00	13,278	1,128,630	0	Nov 25 04:31 PM
Lemaitre Dan	Director	Nov 22 '24	Sale	85.02	1,097	93,263	0	Nov 25 04:31 PM
Scavilla Daniel T	President, CEO	Nov 21 '24	Option Exercise	43.65	130,000	5,674,900	130,000	Nov 25 04:29 PM
Scavilla Daniel T	President, CEO	Nov 21 '24	Sale	85.00	130,000	11,050,000	0	Nov 25 04:29 PM
Davidar David D	Director	Nov 21 '24	Proposed Sale	85.00	20,000	1,700,000		Nov 21 07:12 PM
Davidar David D	Director	Nov 21 '24	Proposed Sale	0.85	20,000	17,000		Nov 21 07:04 PM
Davidar David D	Director	Nov 21 '24	Proposed Sale	84.95	3,500	297,311		Nov 21 06:54 PM
Lemaitre Dan	Director	Nov 21 '24	Proposed Sale	85.00	14,375	1,221,875		Nov 21 06:05 PM
Scavilla Daniel T	Officer	Nov 21 '24	Proposed Sale	84.95	130,000	11,043,000		Nov 21 04:31 PM
Paul David C	Executive Chairman	Nov 15 '24	Option Exercise	24.10	26,042	627,612	26,042	Nov 20 04:15 PM
Scavilla Daniel T	President, CEO	Nov 06 '24	Option Exercise	35.02	60,000	2,101,200	60,000	Nov 08 04:23 PM
Scavilla Daniel T	President, CEO	Nov 06 '24	Sale	80.02	60,000	4,801,200	0	Nov 08 04:23 PM
Huller Kelly	SVP, GC, Corporate Secretary	Nov 06 '24	Option Exercise	24.21	5,000	121,050	5,000	Nov 08 04:21 PM
Huller Kelly	SVP, GC, Corporate Secretary	Nov 06 '24	Sale	81.01	5,000	405,050	0	Nov 08 04:21 PM
Scavilla Daniel T	Officer	Nov 06 '24	Proposed Sale	79.97	60,000	4,798,000		Nov 06 03:41 PM
Huller Kelly	Officer	Nov 06 '24	Proposed Sale	81.00	5,000	405,000		Nov 06 03:25 PM
Huller Kelly	SVP, GC, Corporate Secretary	Oct 16 '24	Option Exercise	25.80	7,500	193,500	7,500	Oct 18 04:39 PM
Davidar David D	Director	Oct 16 '24	Sale	75.04	30,000	2,251,203	536,275	Oct 18 04:23 PM
Davidar David D	Director	Oct 16 '24	Sale	75.03	20,000	1,500,610	185,967	Oct 18 04:23 PM
Huller Kelly	Officer	Oct 16 '24	Proposed Sale	74.97	7,500	562,250		Oct 16 03:46 PM
Davidar David D	Director	Oct 16 '24	Proposed Sale	74.96	3,500	262,350		Oct 16 03:41 PM
Davidar David D	Director	Oct 16 '24	Proposed Sale	75.00	20,000	1,500,000		Oct 16 03:33 PM
Davidar David D	Director	Oct 16 '24	Proposed Sale	75.00	30,000	2,250,000		Oct 16 03:22 PM
RHOADS ANN D	Director	Sep 13 '24	Option Exercise	24.91	35,000	871,900	57,884	Sep 17 04:34 PM
RHOADS ANN D	Director	Sep 13 '24	Sale	70.36	15,000	1,055,400	42,884	Sep 17 04:34 PM
Davidar David D	Director	Sep 13 '24	Option Exercise	25.52	25,000	638,000	591,275	Sep 17 04:31 PM
Davidar David D	Director	Sep 13 '24	Sale	70.46	25,000	1,761,500	566,275	Sep 17 04:31 PM
RHOADS ANN D	Director	Sep 13 '24	Proposed Sale	70.33	15,000	1,055,000		Sep 13 04:03 PM
Davidar David D	Director	Sep 13 '24	Proposed Sale	70.47	25,000	1,761,780		Sep 13 03:55 PM
Norwalk Leslie V	Director	Jul 11 '24	Sale	70.00	1,000	70,000	16,419	Jul 15 04:25 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

GMED

Globus Medical Inc

Upgrade your FINVIZ experience